XNASEKSO
Market cap13mUSD
Dec 24, Last price
0.61USD
1D
0.83%
1Q
-48.74%
Jan 2017
-98.98%
IPO
-99.75%
Name
Ekso Bionics Holdings Inc
Chart & Performance
Profile
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 18,279 41.57% | 12,912 14.81% | 11,246 26.62% | |||||||
Cost of revenue | 33,391 | 28,468 | 25,074 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (15,112) | (15,556) | (13,828) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (476) | (1,332) | ||||||||
Tax Rate | ||||||||||
NOPAT | (15,112) | (15,080) | (12,496) | |||||||
Net income | (15,198) 4.07% | (14,604) 73.20% | (8,432) -50.27% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 661 | 176 | 37,295 | |||||||
BB yield | -1.91% | -1.14% | -114.71% | |||||||
Debt | ||||||||||
Debt current | 1,976 | 2,651 | 229 | |||||||
Long-term debt | 6,641 | 6,282 | 2,222 | |||||||
Deferred revenue | 2,169 | 1,032 | 1,475 | |||||||
Other long-term liabilities | 471 | 374 | 74 | |||||||
Net debt | (21) | (11,592) | (37,955) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (12,054) | (14,688) | (11,156) | |||||||
CAPEX | (157) | (194) | (59) | |||||||
Cash from investing activities | (157) | (5,175) | (59) | |||||||
Cash from financing activities | 348 | 176 | 38,712 | |||||||
FCF | (15,344) | (21,059) | (11,477) | |||||||
Balance | ||||||||||
Cash | 8,638 | 20,525 | 40,406 | |||||||
Long term investments | ||||||||||
Excess cash | 7,724 | 19,879 | 39,844 | |||||||
Stockholders' equity | (238,974) | (223,371) | (208,871) | |||||||
Invested Capital | 261,508 | 257,724 | 249,861 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 13,867 | 12,962 | 12,269 | |||||||
Price | 2.50 110.08% | 1.19 -55.09% | 2.65 -56.77% | |||||||
Market cap | 34,668 124.75% | 15,425 -52.56% | 32,513 -25.96% | |||||||
EV | 34,646 | 3,833 | (5,442) | |||||||
EBITDA | (13,414) | (14,669) | (13,267) | |||||||
EV/EBITDA | 0.41 | |||||||||
Interest | 302 | 156 | 113 | |||||||
Interest/NOPBT |